描述

RNA analysis research covers a wide range of topics-from large-scale analysis of the transcriptome-the complete set of RNA transcripts encoded by a genome-to studying the actions of individual small noncoding RNAs on specific genes. The global RNA analysis market is poised to grow by US$ 6,003.2 期间百万 2022-2028, 复合年增长率为 9.1% 在预测期内, 据数据和分析公司 StrategyHelix 称.

该报告提供了该时期的最新市场规模数据 2018-2021 并预测到 2028 covering key market aspects like sales value for RNA analysis. The global RNA analysis market is segmented on the basis of technology, 和地区. 按技术, the global RNA analysis market has been segmented into microarrays, polymerase chain reaction (PCR), RNAi gene silencing, sequencing technologies. 据研究, the polymerase chain reaction segment had the largest share in the global RNA analysis market. 地理上, the global RNA analysis market is segmented into Asia Pacific, 欧洲, 北美, 事物 (中东和非洲), 拉美. 在 2021, North America made up the largest share of revenue generated by the RNA analysis market.

The global RNA analysis market is highly competitive. The report also includes the profiles of leading companies such as Agilent Technologies Inc., Bio-Rad Laboratories Inc., CD Genomics, Danaher Corp., Eurofins Scientific, Fluidigm Corp., Illumina Inc., Merck KGaA, Promega Corp., Qiagen N.V., Roche Holding AG, Thermo Fisher Scientific Inc.

该报告对于活跃在该行业的公司和组织来说是宝贵的资源. It provides a cohesive picture of the RNA analysis market to help drive informed decision making for industry executives, 政策制定者, 学术的, 和分析师.

报告范围

技术: microarrays, polymerase chain reaction (PCR), RNAi gene silencing, sequencing technologies
地区: 亚太地区, 欧洲, 北美, 事物 (中东和非洲), 拉美
考虑的年数: 本报告涵盖期间 2018 到 2028

利益相关者的主要好处

– Get a comprehensive picture of the global RNA analysis market
– 精准定位增长领域和投资趋势

目录

部分 1. 介绍
– 研究范围
– 学习时段
– 地理范围
– 研究方法论
部分 2. RNA analysis market overview
部分 3. 按技术划分的市场细分
– Microarrays
– Polymerase chain reaction (PCR)
– RNAi gene silencing
– Sequencing technologies
部分 4. 按地区划分的市场细分
– 亚太地区
– 欧洲
– 北美
– 事物 (中东和非洲)
– 拉美
部分 5. 重点企业
– Agilent Technologies Inc.
– Bio-Rad Laboratories, 公司.
– CD Genomics
– Danaher Corp.
– Eurofins Scientific
– Fluidigm Corp.
– Illumina, 公司.
– Merck KGaA
– Promega Corp.
– Qiagen N.V.
– Roche Holding AG
– Thermo Fisher Scientific Inc.
关于StrategyHelix
免责声明